<DOC>
	<DOCNO>NCT02242305</DOCNO>
	<brief_summary>In contrast Hyoscine Butylbromide Capsule 10mg , Study evaluate efficacy safety Hyoscine Butylbromide tablets 10 mg ( 20mg , 3 time daily , orally ) period 3 day treatment occasional recurrent episodes self-reported gastric intestinal spasm-like pain discomfort</brief_summary>
	<brief_title>Study Evaluate Efficacy Safety Hyoscine Butylbromide Tablets Treatment Occasional Recurrent Episodes Gastric Intestinal Spasm-like Pain Discomfort</brief_title>
	<detailed_description />
	<mesh_term>Abdominal Pain</mesh_term>
	<mesh_term>Scopolamine Hydrobromide</mesh_term>
	<mesh_term>Butylscopolammonium Bromide</mesh_term>
	<criteria>1 . Written Informed Consent give patient 2 . Male female patient age 18 70 3 . Subjects occasional recurrent episode gastric intestinal spasmlike pain , discomfort , occur e.g . irritable bowel syndrome , present least 3 month 4 . The pain intensity score upon screen least 4 cm VAS score 1 . Patients follow concomitant disease eligible enrolment Painful gastric intestinal spasm organic origin Crohn 's disease , ulcerative colitis , lactose intolerance , gastritis , ulcer . Exception : diverticulitis mild gastritis dominant symptom cramp pain , ineligible heartburn reflux dominant symptom Pain related malignancy Patients severe pain state organic origin Mechanical stenosis gastrointestinal tract , megacolon Urinary retention associate mechanical stenosis urinary tract Narrowangled glaucoma Tachyarrhythmia Myasthenia gravis MeulengrachtGilbert syndrome Known depression know mental illness , anxiety disturbance 2 . Frequent vomit might prevent adequate absorption active ingredient filmcoated tablet take 3 . Patients take follow concomitant medication eligible enrolment Analgesics Spasmolytics Anticholinergics Affecting gastrointestinal motility , propantheline metoclopramide , cisapride , loperamide , diphenoxylate , opioid analgesic , antacid ulcer treatment Regular administration laxatives Narcotics Antidepressant treatment treatment psychoactive drug 4 . Pregnancy and/or lactation plan pregnancy 5 . Known hypersensitivity Nbutylscopolammonium bromide 6 . Alcohol drug abuse 7 . Simultaneous participate another clinical trial , discontinue another clinical trial randomization ( administration study medication ) ; moreover , case screening failure premature discontinue trial , repeat enrolment forbidden 8 . Unwilling unable complete entire trial procedure accord protocol 9 . In investigator 's opinion , patient proper trial</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>September 2014</verification_date>
</DOC>